Advertisement
Alvotech

Alvotech (ALVOW) Stock Overview

Explore Alvotech’s financial performance, market position, analyst ratings, and future outlook.

ALVOWNASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.32
$0.08(31.25%)
U.S. Market opens in 53h 40m
Advertisement

Alvotech (ALVOW)

Meyka AI Score

Z

Key Financials

Market Cap2B
P/E Ratio-17.14
EPS (TTM)N/A
ROE0.35%
Fundamental Analysis

AI Price Forecasts

1 Month$-0.54
3 Months$0.00
1 Year Target$0.00

ALVOW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Alvotech (ALVOW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.27, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -17.14 and a market capitalization of 2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
31.25%
5-Day Change
43.12%
1-Month Change
26.00%
3-Month Change
-4.57%
6-Month Change
-66.89%
Year-to-Date (YTD) Change
-51.53%
1-Year Change
-83.76%
3-Year Change
-67.19%
5-Year Change
-75.95%
All-Time (Max) Change
-71.36%

Contact Information

354 422 4500
Saemundargata 15-19, Luxembourg, NaN, 102

Company Facts

10,120 Employees
IPO DateJun 16, 2022
CountryIS
Actively Trading

Frequently Asked Questions